| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Service
d'Hépatogastroentérologie,*
INSERM U
402
and Service
d'Anatomopathologie,
CHU Saint-Antoine,
Paris INSERM U 397,§
CHU Rangueil, Toulouse,
France; and the Department of Radiation Oncology,¶
University of North Carolina at Chapel Hill, Chapel Hill,
North Carolina
We tested the potential role of vascular endothelial growth factor (VEGF) and of fibroblast growth factor-2 (FGF-2) in the angiogenesis associated with experimental liver fibrogenesis induced by common bile duct ligation in Sprague-Dawley rats. In normal rats, VEGF and FGF-2 immunoreactivities were restricted to less than 3% of hepatocytes. One week after bile duct ligation, hypoxia was demonstrated by the immunodetection of pimonidazole adducts unevenly distributed throughout the lobule. After 2 weeks, hypoxia and VEGF expression were detected in >95% of hepatocytes and coexisted with an increase in periportal vascular endothelial cell proliferation, as ascertained by Ki67 immunolabeling. Subsequently, at 3 weeks the density of von Willebrand-labeled vascular section in fibrotic areas significantly increased. Semiquantitative reverse transcription polymerase chain reaction showed that VEGF120 and VEGF164 transcripts, that correspond to secreted isoforms, increased within 2 weeks, while VEGF188 transcripts remained unchanged. FGF-2 mainly consisting of a 22-kd isoform, according to Western blot, was identified by immunohistochemistry in 49% and 100% of hepatocytes at 3 and 7 weeks, respectively. Our data provide evidence that in biliary-type liver fibrogenesis, angiogenesis is stimulated primarily by VEGF in response to hepatocellular hypoxia while FGF-2 likely contributes to the maintenance of angiogenesis at later stages.
This article has been cited by other articles:
 |
|
 |
|
  L. Fouassier, M. Beaussier, E. Schiffer, C. Rey, V. Barbu, M. Mergey, D. Wendum, P. Callard, J.-Y. Scoazec, E. Lasnier, et al. Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G25 - G35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Novo, S. Cannito, E. Zamara, L. V. di Bonzo, A. Caligiuri, C. Cravanzola, A. Compagnone, S. Colombatto, F. Marra, M. Pinzani, et al. Proangiogenic Cytokines as Hypoxia-Dependent Factors Stimulating Migration of Human Hepatic Stellate Cells Am. J. Pathol., June 1, 2007; 170(6): 1942 - 1953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kanematsu, S. Osada, N. Amaoka, S. Goshima, H. Kondo, H. Nishibori, H. Kato, M. Matsuo, R. Yokoyama, H. Hoshi, et al. Expression of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma and the Surrounding Liver: Correlation with Angiographically Assisted CT Am. J. Roentgenol., December 1, 2004; 183(6): 1585 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Ward, A. L. Haninec, P. Van Slyke, J. G. Sled, C. Sturk, R. M. Henkelman, I. R. Wanless, and D. J. Dumont Angiopoietin-1 Causes Reversible Degradation of the Portal Microcirculation in Mice: Implications for Treatment of Liver Disease Am. J. Pathol., September 1, 2004; 165(3): 889 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Smith, A. Nyska, and C. Portier Application of a Statistical Dynamic Model Investigating the Short-Term Cellular Kinetics Induced by Riddelliine, a Hepatic Endothelial Carcinogen Toxicol. Sci., August 1, 2004; 80(2): 258 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Yoshiji, S Kuriyama, J Yoshii, Y Ikenaka, R Noguchi, D J Hicklin, Y Wu, K Yanase, T Namisaki, M Yamazaki, et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis Gut, September 1, 2003; 52(9): 1347 - 1354. [Abstract] [Full Text]
|
|
|
|
|
|
T. V. Masyuk, E. L. Ritman, and N. F. LaRusso Hepatic Artery and Portal Vein Remodeling in Rat Liver: Vascular Response to Selective Cholangiocyte Proliferation Am. J. Pathol., April 1, 2003; 162(4): 1175 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ohashi, A. Shimizu, Y. Masuda, H. Kitamura, M. Ishizaki, Y. Sugisaki, and N. Yamanaka Peritubular Capillary Regression during the Progression of Experimental Obstructive Nephropathy J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1795 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Mazure, C. Chauvet, B. Bois-Joyeux, M.-A. Bernard, H. Nacer-Cherif, and J.-L. Danan Repression of {alpha}-Fetoprotein Gene Expression under Hypoxic Conditions in Human Hepatoma Cells: Characterization of a Negative Hypoxia Response Element That Mediates Opposite Effects of Hypoxia Inducible Factor-1 and c-Myc Cancer Res., February 1, 2002; 62(4): 1158 - 1165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Corpechot, V. Barbu, D. Wendum, N. Chignard, C. Housset, R. Poupon, and O. Rosmorduc Hepatocyte Growth Factor and c-Met Inhibition by Hepatic Cell Hypoxia : A Potential Mechanism for Liver Regeneration Failure in Experimental Cirrhosis Am. J. Pathol., February 1, 2002; 160(2): 613 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Pillebout, M. Burtin, H. T. Yuan, P. Briand, A. S. Woolf, G. Friedlander, and F. Terzi Proliferation and Remodeling of the Peritubular Microcirculation after Nephron Reduction : Association with the Progression of Renal Lesions Am. J. Pathol., August 1, 2001; 159(2): 547 - 560. [Abstract] [Full Text]
|
|
|
|
|
|
C. C. Wykoff, N. J. P. Beasley, P. H. Watson, K. J. Turner, J. Pastorek, A. Sibtain, G. D. Wilson, H. Turley, K. L. Talks, P. H. Maxwell, et al. Hypoxia-inducible Expression of Tumor-associated Carbonic Anhydrases Cancer Res., December 1, 2000; 60(24): 7075 - 7083. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
